Review
Published on 25 Oct 2023
Emerging theragnostic radionuclide applications for hepatocellular carcinoma
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2023.1210982
- 4,233 views
- 5 citations
195 Publications
volumes
Volume 3 - 2023
Hypothesis and Theory
Published on 13 Oct 2023
Radiopharmaceutical administration practices—Are they best practice?
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2023.1244660
- 5,748 views
- 5 citations
Mini Review
Published on 09 Oct 2023
Mini review of first-in-human integrin αvβ6 PET tracers
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2023.1271208
- 6,833 views
- 13 citations
![[18F]NaF PET/CT imaging of response to single fraction SABR to bone metastases from breast cancer](https://www.frontiersin.org/files/myhome article library/1197397/1197397_Thumb_400.jpg)
Brief Research Report
Published on 04 Oct 2023
[18F]NaF PET/CT imaging of response to single fraction SABR to bone metastases from breast cancer
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2023.1197397
- 2,638 views
- 2 citations
Review
Published on 21 Sep 2023
Evaluation of deep space exploration risks and mitigations against radiation and microgravity
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2023.1225034
- 17,299 views
- 26 citations
Original Research
Published on 20 Sep 2023
Radiolabeled iron oxide nanoparticles functionalized with PSMA/BN ligands for dual-targeting of prostate cancer
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2023.1184309
- 3,512 views
- 3 citations
Original Research
Published on 14 Sep 2023
Multicentric 68Ga-PSMA PET radiomics for treatment response assessment of 177Lu-PSMA-617 radioligand therapy in patients with metastatic castration-resistant prostate cancer
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2023.1234853
- 4,842 views
- 9 citations
Original Research
Published on 12 Sep 2023
Post-acquisition standardization of positron emission tomography images
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2023.1210931
- 2,092 views
- 3 citations
Perspective
Published on 05 Sep 2023
To tell or not to tell … the patient about potential harm
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2023.1258960
- 2,307 views
Case Report
Published on 24 Aug 2023
Case report: 18F-FDG PET-CT findings in Bickerstaff encephalitis before and after treatment
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2023.1235173
- 2,217 views
Review
Published on 04 Aug 2023
Theranostics in breast cancer
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2023.1236565
- 12,022 views
- 16 citations
Case Report
Published on 03 Aug 2023
Case report: Peptide receptor radioligand therapy in metastatic pediatric neuroendocrine tumors
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2023.1193880
- 2,421 views
- 3 citations
Opinion
Published on 31 Jul 2023
Critique and discussion of “Multicenter evaluation of frequency and impact of activity infiltration in PET imaging, including microscale modeling of skin-absorbed dose”
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2023.1240162
- 1,618 views
- 1 citation
Original Research
Published on 28 Jul 2023
A systematic evaluation of five different image-derived input functions for the clinical implementation of 18F-NaF bone PET/CT in patients with chronic kidney disease–mineral and bone disorder
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2023.1235800
- 2,143 views
Review
Published on 27 Jul 2023
Gallium-68 fibroblast activation protein inhibitor positron emission tomography in cardiovascular disease
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2023.1224905
- 3,302 views
- 1 citation
Review
Published on 25 Jul 2023
Biodosimetry, can it find its way to the nuclear medicine clinic?
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2023.1209823
- 6,037 views
- 4 citations
Mini Review
Published on 20 Jul 2023
Radiopharmaceutical extravasations: a twenty year mini-review
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2023.1219202
- 3,717 views
- 1 citation
Mini Review
Published on 18 Jul 2023
Tumor microenvironment and fibroblast activation protein inhibitor (FAPI) PET: developments toward brain imaging
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2023.1183471
- 4,287 views
- 9 citations
Perspective
Published on 27 Jun 2023
The changing landscape of nuclear medicine and a new era: the “NEW (Nu) CLEAR Medicine”: a framework for the future
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2023.1213714
- 9,196 views
- 11 citations
Mini Review
Published on 23 Jun 2023
A brief overview of targeted radionuclide therapy trials in 2022
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2023.1169650
- 8,386 views
- 9 citations
Original Research
Published on 21 Jun 2023
Investigation and optimization of PET-guided SPECT reconstructions for improved radionuclide therapy dosimetry estimates
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2023.1124283
- 3,444 views
- 5 citations
Original Research
Published on 30 May 2023
Diagnostic accuracy of the latest-generation digital PET/CT scanner for detection of metastatic lymph nodes in head and neck cancer
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2023.1184448
- 6,009 views
- 3 citations
Original Research
Published on 17 May 2023
Development and validation of radiomic signature for predicting overall survival in advanced-stage cervical cancer
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2023.1138552
- 3,813 views
- 5 citations
Case Report
Published on 17 May 2023
Case report: Intraosseous hibernoma (IOH) mimics osseous metastasis: another rare pitfall in FDG-PET-CT
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2023.1150143
- 1,792 views
- 3 citations